Gold Nanoparticles Companies

The gold nanoparticles market is projected to grow from USD 0.50 Billion in 2024 to USD 1.11 Billion by 2029, at a CAGR of 16.3% during the forecast period.

The key drivers of the gold nanoparticles market are the growing demand for gold nanoparticles in various end-use industries mainly in pharmaceutical & healthcare and unique properties of gold nanoparticles. Stringent environmental regulations by the government are pushing the manufacturers to adopt gold nanoparticles in various applications like imaging, targeted drug delivery, proton therapy, in-vitro assays, sensors, probes, catalysis and others. Companies like BBI Solutions, Cytodiagnostics Inc, Fortis Life Sciences, LLC., TANAKA PRECIOUS METAL GROUP Co., Ltd. and Merck KGaA are strategically positioning themselves in the gold nanoparticles market by increasing the production capacities of the gold nanoparticles to fulfil the needs of pharmaceutical & healthcare, electrical & electronics, chemicals, personal care & cosmetics, and other end use industries. Major pharmaceutical & healthcare manufacturers are utilizing gold nanoparticles for the properties such as biocompatibility, stability and unique optical properties. Gold nanoparticles play crucial roles in targeted drug delivery applications.

To know about the assumptions considered for the study download the pdf brochure

Gold Nanoparticles Companies

The major players active in the gold nanoparticles market are based in North America, Europe, and Asia Pacific region. BBI Solutions (UK), Cytodiagnostics Inc (Canada), Fortis Life Sciences, LLC. (US), Meliorum Technologies, Inc (US), TANAKA PRECIOUS METAL GROUP Co., Ltd. (Japan), Merck KGaA (Germany), Nanopartz, Inc (US), CD Bioparticles (US), Nano Labs (India), Nanocs Inc. (US) are among a few leading players operating in the gold nanoparticles market. Significant attention has been dedicated to developing cost-effective manufacturing technology in the gold nanoparticles market to meet evolving global demands. Key players have implemented various growth strategies to solidify their market position. These strategies encompass deals, mergers and acquisitions, and, investment & expansions, all aimed at enhancing their presence in the gold nanoparticles market.

BBI Solutions (UK)

BBI Solutions is one of the leading global providers of products related to global dygnostic industry with complete ISO certification. The company provides services in antibody development, antibody manufacturing, antibody customization and gold conjugation. The company offers gold nanoparticles in sizes ranging from 2nm – 250nm for various applications like transmission electron microscopy (TEM) and scanning electron microscopy (SEM), lateral flow assays, environmental detection and purification, data storage, biomarkers, SERS, photo-thermolysis, catalysis, chemical sensors, and DNA detection.  It provides gold nanoparticles in Europe. The company has manufacturing facility (120,000 sq. Feet) in Crumlin, Wales. BBI Solutions has presence in North America, South America, Asia Pacific, Africa and Europe.

Cytodiagnostics Inc (Canada)

Cytodiagnostics Inc is one of the prominent players in the gold nanoparticles market. The company has been the pre-eminent global supplier of gold and silver nanoparticles. It has around 40 customers in over 40 countries worldwide. The company focus on four simple missions which are product innovation & satisfaction, custom R&D, worldwide distribution and collaboration, through this the company focus more on product innovation, customer satisfaction, new research and developments and their distribution network. The company has distribution channel in regions like North America, Europe, Middle East and South America.

Fortis Life Sciences, LLC. (US)

Fortis Life Sciences, LLC. is one of the prominent players in the gold nanoparticles market. The company has 5 North American manufacturing and R&D locations, including three ISO 13485 and GMP certified sites. It also has about 500 biopharma, diagnostics, research and applied technology customers globally. The company offers diverse range of product such as antibodies & antigens, assays & kits, buffers, bulk & OEM, diagnostic components, enzymes & master mixes, nanoparticles and viral vectors. Fortis Life Sciences is a trusted partner to life science and diagnostics companies. They offer an integrated portfolio of reagents, components, and service solutions. Their services include CDMO (Contract Development and Manufacturing Organization) services and Contract R&D. The company has a team of about 200 experts to find innovative solutions. The company has acquired nanoComposix, which is based in San Diego, USA. Gold nanoparticles are provided under the nanoComposix company. The company provides products such as 2 nm Dodecanethiol-Stabilized Gold Nanospheres, 5 nm Gold Nanospheres, 50 nm Ultra Uniform Gold Nanospheres, and Peak λ 650 nm Gold Nanorods. It provides gold nanoparticles ranging from 5nm-100nm. The company has distributors in around 63 countries, with its operations in region like North America, Asia Pacific, Europe, Middle East and Africa and South America.

Related Reports:

Gold Nanoparticles Market by Process (Physical, Chemical, Biological), Application (Imaging, Targeted Drug Delivery, Proton Therapy, In-Vitro Assays, Sensors, Probes, Catalysis), End-Use Industry and Region - Global Forecast to 2029